Charles Explorer logo
🇬🇧

Combination of niacin and laropiprant: another possibility of influencing not only dyslipidemia

Publication at First Faculty of Medicine |
2011

Abstract

The derivate of nicotin acid – niacin provides significant potential to affect dyslipidemia with stopping progression of atherosclerosis at the same time. The modern formulation offers a wider use and lower incidence of side effects.